Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX)
Historical Holders from Q4 2024 to Q3 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.00005 GBP per share
-
Symbol
-
BDRX on Nasdaq
-
Shares outstanding
-
25,770,441,176
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
0
-
Holdings value
-
$0
-
Share change
-
-19,666
-
Value change
-
-$17,010
-
Average sells %
-
-0%
-
Number of holders
-
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
C/M CAPITAL PARTNERS, LP
|
6.8%
|
|
$2,611,061,100
|
+$2,611,061,100
|
1,752,390,000
|
|
Jonathan Juchno
|
20 May 2025
|
As of 30 Sep 2025, Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) has 0 institutional shareholders filing 13F forms.
They hold 0 shares
of 25,770,441,176 outstanding shares (0%)
.
Institutional Holders of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) across Reporting Periods
| Period |
Reported Shares, Excl. Options |
Value, Excl. Options |
Value Change |
Puts Notional Value |
Calls Notional Value |
Price |
Investors |
|
2025 Q3
|
0 |
$0 |
-$17,010 |
|
|
|
0 |
|
2025 Q2
|
19,666 |
$17,010 |
-$1,756 |
|
|
$0.8649 |
4 |
|
2025 Q1
|
21,314 |
$28,132 |
+$18,574 |
|
|
$1.32 |
6 |
|
2024 Q4
|
7,242 |
$29,334 |
+$29,330 |
|
|
$4.05 |
4 |